Aemetis, Inc (AMTX) stock
AMTXNasdaqIndustrial Organic ChemicalsFiscal year ends December 31
$1.09−0.09 (-7.63%)
Close on Nov 17, 2026Market cap $78.66MP/E –Yield –
Aemetis r&d expenses
Research and development expenses are spending on new products and technology.
Aemetis's R&D Expenses for the twelve months ending Dec 31, 2023 was $152.00K, down 15.6% year over year. For fiscal 2023 it was $152.00K, down 15.6% from the year before. Over ten years it grew -11.9% a year on average. The highest annual figure on record is $2.37M in fiscal 2017.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $152.00K | -15.6% |
| FY2022 | Dec 31, 2022 | $180.00K | +104.5% |
| FY2021 | Dec 31, 2021 | $88.00K | -58.7% |
| FY2020 | Dec 31, 2020 | $213.00K | +3.9% |
| FY2019 | Dec 31, 2019 | $205.00K | -16.7% |
| FY2018 | Dec 31, 2018 | $246.00K | -89.6% |
| FY2017 | Dec 31, 2017 | $2.37M | +541.5% |
| FY2016 | Dec 31, 2016 | $369.00K | -17.4% |
| FY2015 | Dec 31, 2015 | $447.00K | -2.6% |
| FY2014 | Dec 31, 2014 | $459.00K | -14.8% |
| FY2013 | Dec 31, 2013 | $539.00K | -13.1% |
| FY2012 | Dec 31, 2012 | $620.00K | +7.5% |
| FY2011 | Dec 31, 2011 | $576.63K | +78.8% |
| FY2010 | Dec 31, 2010 | $322.56K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $37.00K | -9.8% |
| Q3 FY2023 | Sep 30, 2023 | $36.00K | -30.8% |
| Q2 FY2023 | Jun 30, 2023 | $37.00K | -27.5% |
| Q1 FY2023 | Mar 31, 2023 | $42.00K | +16.7% |
| Q4 FY2022 | Dec 31, 2022 | $41.00K | +86.4% |
| Q3 FY2022 | Sep 30, 2022 | $52.00K | +136.4% |
| Q2 FY2022 | Jun 30, 2022 | $51.00K | +142.9% |
| Q1 FY2022 | Mar 31, 2022 | $36.00K | +56.5% |
| Q4 FY2021 | Dec 31, 2021 | $22.00K | -42.1% |
| Q3 FY2021 | Sep 30, 2021 | $22.00K | -40.5% |
| Q2 FY2021 | Jun 30, 2021 | $21.00K | 0.0% |
| Q1 FY2021 | Mar 31, 2021 | $23.00K | -80.3% |
| Q4 FY2020 | Dec 31, 2020 | $38.00K | -15.6% |
| Q3 FY2020 | Sep 30, 2020 | $37.00K | 0.0% |
| Q2 FY2020 | Jun 30, 2020 | $21.00K | -76.7% |
| Q1 FY2020 | Mar 31, 2020 | $117.00K | +254.5% |
| Q4 FY2019 | Dec 31, 2019 | $45.00K | -18.2% |
| Q3 FY2019 | Sep 30, 2019 | $37.00K | -50.0% |
| Q2 FY2019 | Jun 30, 2019 | $90.00K | +63.6% |
| Q1 FY2019 | Mar 31, 2019 | $33.00K | -46.8% |
| Q4 FY2018 | Dec 31, 2018 | $55.00K | -81.4% |
| Q3 FY2018 | Sep 30, 2018 | $74.00K | -96.1% |
| Q2 FY2018 | Jun 30, 2018 | $55.00K | -50.0% |
| Q1 FY2018 | Mar 31, 2018 | $62.00K | -27.9% |
| Q4 FY2017 | Dec 31, 2017 | $295.00K | +273.4% |
| Q3 FY2017 | Sep 30, 2017 | $1.88M | +2056.3% |
| Q2 FY2017 | Jun 30, 2017 | $110.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $86.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $79.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $87.00K | – |
See a number that looks wrong?